Paula Jimenez-Fonseca

33PUBLICATIONS
119CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targetsGene expression (incl. microarray and other genome-wide approaches)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (33)

|Jul 14, 2026
Angiotensin system inhibitors as adjunctive therapy in esophageal adenocarcinoma: hypothesis-generating insights from incidental use during trimodal treatment.

|Apr 04, 2026
Durvalumab plus tremelimumab for the treatment of patients with progressive, refractory advanced thyroid carcinoma: the phase II GETNE-DUTHY trial.

Jaume Capdevila, Jorge Hernando, Javier Molina-Cerillo

|Nov 26, 2025
Does perioperative FLOT increase cure rates in resectable esophageal adenocarcinoma? A mixture cure model analysis.

Lucía Mateos, Paula Jiménez-Fonseca, Javier Gallego

|Sep 12, 2025
Cabozantinib plus Atezolizumab in Advanced, Progressive Endocrine Malignancies: A Multicohort, Basket, Phase II Trial (CABATEN/GETNE-T1914).

Jaume Capdevila, Jorge Hernando, Javier Molina-Cerrillo

|Aug 14, 2025
External validation of the S-GRAS score for predicting recurrence in patients with adrenocortical carcinoma: implications for adjuvant mitotane therapy.

Paula Jimenez-Fonseca, Cristina Álvarez-Escola, Inmaculada Ballester Navarro

|Jul 12, 2025
Treatment and Outcomes in Advanced Gastroesophageal Adenocarcinoma in the Pre-Immunotherapy Era Based on the Spanish AGAMENON-SEOM Registry.

Paula Jimenez-Fonseca, Alberto Carmona-Bayonas, Jaime Álvarez-Cañada

Pageof 6

Frequent Collaborators

19 joint publications

Paula Jimenez-Fonseca

10 joint publications

Caterina Calderon

7 joint publications

Raquel Hernández-San Gil

5 joint publications

Patricia Cruz-Castellanos